Massachusetts Financial Services’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

Massachusetts Financial Services’s Portfolio TPTX Stock Details TPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-365,205	Closed	-$9.81M	–	905
2022 Q1	$9.81M	Buy	365,205 +10,012	+3%	+$336K	﹤0.01%	636
2021 Q4	$16.9M	Buy	355,193 +73,469	+26%	+$3.28M	﹤0.01%	621
2021 Q3	$18.7M	Sell	281,724 -3,677	-1%	-$262K	0.01%	620
2021 Q2	$22.3M	Buy	285,401 +100,742	+55%	+$7.44M	0.01%	603
2021 Q1	$17.5M	Sell	184,659 -4,289	-2%	-$510K	0.01%	614
2020 Q4	$23M	Buy	188,948 +67,285	+55%	+$7.37M	0.01%	578
2020 Q3	$10.6M	Buy	+121,663	New	+$8.48M	﹤0.01%	627

Other funds holding TPTX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Massachusetts Financial Services's TPTX Position: Q2 2022 in Review

Massachusetts Financial Services sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q2 2022, closing a stake of 365,205 shares — an estimated $9.81M sold.

Massachusetts Financial Services first reported a position in TPTX in Q3 2020 and held it in 7 quarters. The position peaked at $23M in Q4 2020. 208 funds tracked by Wall St. Rank hold TPTX as of Q2 2022.

Massachusetts Financial Services reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Massachusetts Financial Services sold 365,205 Turning Point Therapeutics, Inc. Common Stock shares in Q2 2022, an estimated $9.81M.
Massachusetts Financial Services first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q3 2020 and held it in 7 quarters.
Massachusetts Financial Services's Turning Point Therapeutics, Inc. Common Stock position peaked at $23M in Q4 2020.
208 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q2 2022.

Based on Massachusetts Financial Services's 13F filing for Q2 2022, filed 9 Aug 2022.